{"id": "1341678573984346113", "creation": 1608716073.0, "user_id": "15754217", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}}, "text": "#Safety and #immunogenicity of a recombinant tandem-repeat dimeric #RBD protein #vaccine against #COVID19 in adults: pooled analysis of two randomized, double-blind, placebo-controlled, phase 1 and 2 trials (MedRxIV,\u00a0abstract) https://t.co/wD0RDoz4Qj", "first_save": 1634559108.199414, "hashtags": ["#SAFETY", "#IMMUNOGENICITY", "#RBD", "#VACCINE", "#COVID19"]}